Welcome

 Cell>Point is completing the development of universal oncology, cardiology, stroke and diabetes molecular imaging agents in addition to intra-nuclear metallic therapeutics. The company has five platform technologies licensed from The University of Texas M.D. Anderson Cancer Center.

Our agents are designed to improve diagnosis and monitor treatment while lowering healthcare cost.

Clinical trials are being conducted at the Mayo Clinic, Johns Hopkins, Montefiore Medical Center, Decatur Memorial Hospital, Baptist Hospital of Miami, the University of Chicago Medical Center, and British Columbia Medical Center (Canada). Cell>Point is a private company with headquarters in Centennial, Colorado .

In The News

	Overview
	KCFR / NPR
	ABC 7 News, Denver
	NBC 9 News, Denver